Last Updated: September 24, 2026

TPN ELECTROLYTES IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Tpn Electrolytes In Plastic Container, and when can generic versions of Tpn Electrolytes In Plastic Container launch?

Tpn Electrolytes In Plastic Container is a drug marketed by Abbott and Hospira and is included in two NDAs.

The generic ingredient in TPN ELECTROLYTES IN PLASTIC CONTAINER is calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for TPN ELECTROLYTES IN PLASTIC CONTAINER?
  • What are the global sales for TPN ELECTROLYTES IN PLASTIC CONTAINER?
  • What is Average Wholesale Price for TPN ELECTROLYTES IN PLASTIC CONTAINER?
Summary for TPN ELECTROLYTES IN PLASTIC CONTAINER
Recent Clinical Trials for TPN ELECTROLYTES IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Daping Hospital and the Research Institute of Surgery of the Third Military Medical UniversityPHASE4
Martin RohacekPHASE4
Ifakara Health Institute (IHI)PHASE4

See all TPN ELECTROLYTES IN PLASTIC CONTAINER clinical trials

US Patents and Regulatory Information for TPN ELECTROLYTES IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbott TPN ELECTROLYTES IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride INJECTABLE;INJECTION 019399-001 Jun 16, 1986 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hospira TPN ELECTROLYTES IN PLASTIC CONTAINER calcium chloride; magnesium chloride; potassium chloride; sodium acetate; sodium chloride INJECTABLE;INJECTION 018895-001 Jul 20, 1984 RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.